Atea Pharmaceuticals, Inc. amended their bylaws to address proxy rules and enhance procedural mechanics and disclosure requirements. They also held their 2023 Annual Meeting of Stockholders, electing two directors and approving the appointment of KPMG LLP as their independent registered public accounting firm.